logo

Global Pediatric Drugs Market Size (2024 - 2029)

The pediatric drugs market is projected to experience significant growth over the forecast period, driven by an increase in the birth rate and a rise in fatal pediatric cases due to various health challenges. The market's expansion is influenced by the need for effective treatments for conditions such as viral infections, GI disorders, and malnutrition, which have been exacerbated by the COVID-19 pandemic. The pandemic's impact on children's health has highlighted the importance of adapting healthcare provisions, further contributing to the market's growth.

Home Market Analysis Healthcare Research Pharmaceuticals Research Pediatric Drugs Market Market Size

Market Size of Global Pediatric Drugs Industry

Pediatric Drugs Market Size
Study Period 2019 - 2029
Market Size (2024) USD 130.37 Billion
Market Size (2029) USD 194.77 Billion
CAGR (2024 - 2029) 8.36 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Pediatric Drugs Market Key Players

*Disclaimer: Major Players sorted in no particular order

Pediatric Drugs Market Analysis

The Global Pediatric Drugs Market size is estimated at USD 130.37 billion in 2024, and is expected to reach USD 194.77 billion by 2029, growing at a CAGR of 8.36% during the forecast period (2024-2029).

The COVID-19 pandemic impacted the global pediatric drug market. In the business world, the COVID-19 pandemic has created unprecedented economic uncertainty. While some businesses are relatively insulated due to low exposure, many others have been unable to avoid the pandemic's effects and are experiencing financial hardship. The COVID-19 pandemic and subsequent public health guidance to reduce the spread of the disease have wide-reaching implications for children's health and wellbeing. Pediatric emergency departments (EDs) have rapidly adapted the provision of care in response to the pandemic.

The major factors attributing to the growth of the pediatric drugs market are a rise in the birth rate compared to previous years and the increased volume of fatal pediatric cases, which are leading to even deaths due to various diseases, viral infections, GI disorders, lung cancers, and malnutrition. According to the United Nations International Children's Emergency Fund (UNICEF) 2020 Report, 5.0 million children under five were expected to die by 2020. In 2020, this translated to 13,800 children under five dying each day. Infectious diseases such as pneumonia, diarrhea, and malaria, and preterm birth and intrapartum complications continue to be the leading causes of death among children under the age of five worldwide. Hence, deaths among children under age five demand efficient treatment. The rise in prevalence of renal or pulmonary dysfunctions following hematopoietic stem-cell transplantations (HSCT) due to defective or low immunity results in the growth of the global pediatric drugs market.

Pediatric Drugs Industry Segmentation

Pediatric medicine is a branch of medicine that deals with the medical care, development, and related diseases of infants, children, and adolescents. The pediatric drugs market grows significantly as children often suffer from gastrointestinal, allergic, respiratory, and other chronic diseases due to their lower immunity. The market is segmented by Drug Type (Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovascular Drugs, and Other Drug Types), Route of Administration (Oral, Topical, Parenteral, and Other Routes of Administration), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

Drug Type
Respiratory Disorder Drugs
Autoimmune Disorder Drugs
Gastrointestinal Drugs
Cardiovascular Drugs
Other Drug Types
Route of Administration
Oral
Topical
Parenteral
Other Routes of Administration
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Pediatric Drugs Market Size Summary

The pediatric drugs market is poised for significant growth, driven by an increase in birth rates and the rising prevalence of serious health conditions among children. The market is experiencing a surge in demand for treatments addressing various diseases, including viral infections, gastrointestinal disorders, and respiratory conditions like Chronic Obstructive Pulmonary Disease (COPD). The COVID-19 pandemic has further highlighted the need for efficient pediatric healthcare solutions, as it has impacted children's health and altered care delivery in pediatric emergency departments. The market is characterized by a strong focus on developing drugs for rare autoimmune disorders, spurred by the growing incidence of these conditions alongside cancers and genetic disorders. This has led to expedited drug approvals and a push for innovative treatments, contributing to the market's expansion.

North America is expected to lead the pediatric drugs market, supported by advanced healthcare technologies and a high volume of pediatric cases requiring specialized treatments. The region benefits from proactive government initiatives and regulatory support, such as the USFDA's accelerated drug approval processes, which encourage the development of pediatric medicines. The market is moderately competitive, with major players like BioMarin Pharmaceutical Inc., Horizon Therapeutics PLC, and Gilead Sciences Inc. actively launching new products to meet unmet medical needs. The increasing disposable income and improvements in healthcare infrastructure globally are anticipated to further bolster market growth during the forecast period.

Explore More

Global Pediatric Drugs Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Burden of Pediatric Diseases such as Diabetes, Respiratory Disorders, and Rise in Affordability with Disposable Income

      2. 1.2.2 Increased R&D Activities and Awareness of Pediatric Medicine Among Public

    3. 1.3 Market Restraints

      1. 1.3.1 Small Size of Study Population and Ethical Issues in Pediatric Research

      2. 1.3.2 Risk of Severe Complications Associated with Medicines that may lead to Death

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 Drug Type

      1. 2.1.1 Respiratory Disorder Drugs

      2. 2.1.2 Autoimmune Disorder Drugs

      3. 2.1.3 Gastrointestinal Drugs

      4. 2.1.4 Cardiovascular Drugs

      5. 2.1.5 Other Drug Types

    2. 2.2 Route of Administration

      1. 2.2.1 Oral

      2. 2.2.2 Topical

      3. 2.2.3 Parenteral

      4. 2.2.4 Other Routes of Administration

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Pediatric Drugs Market Size FAQs

The Global Pediatric Drugs Market size is expected to reach USD 130.37 billion in 2024 and grow at a CAGR of 8.36% to reach USD 194.77 billion by 2029.

In 2024, the Global Pediatric Drugs Market size is expected to reach USD 130.37 billion.

Pediatric Drugs Market Report Snapshots

Pediatric Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)